BBA
TDOC icon

Braun-Bostich & Associates’s Teladoc Health TDOC Stock Holding History

Braun-Bostich & Associates’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$22K – 196
2020
Q3 		$22K Hold
100
– – 0.02% 207
2020
Q2 		$19K Hold
100
– – 0.02% 177
2020
Q1 		$16K Buy
+100
New +$11.6K 0.02% 180

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braun-Bostich & Associates's TDOC Position: Q4 2020 in Review

Braun-Bostich & Associates sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 100 shares — an estimated $22K sold.

Braun-Bostich & Associates first reported a position in TDOC in Q1 2020 and held it in 3 quarters. The position peaked at $22K in Q3 2020. 900 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

  • Braun-Bostich & Associates reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
  • Braun-Bostich & Associates sold 100 Teladoc Health shares in Q4 2020, an estimated $22K.
  • Braun-Bostich & Associates first reported a position in Teladoc Health in Q1 2020 and held it in 3 quarters.
  • Braun-Bostich & Associates's Teladoc Health position peaked at $22K in Q3 2020.
  • 900 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on Braun-Bostich & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.